Our Team

OUR ROYAL PATRON

His Royal Highness, The Prince of Wales

I have been Patron of this inspiring charity for 20 years and I am enormously proud of the vital work it does in supporting those with breast cancer.

Today, 150 women in the United Kingdom will hear the life-changing news that they have breast cancer. Currently, in the U.K., 600,000 people are living with, and beyond, breast cancer.

Our N.H.S. provides excellent medical treatment, but often this can have arduous physical and psychological impacts on patients, and in turn, on their loved ones.

Unavoidably, I know there have been agonizing delays in cancer diagnosis, treatment and surgery due to this dreadful pandemic, and this has resulted in an inevitable backlog for medical care. Breast Cancer Haven is here to support these patients during what is, inevitably, a most anxious time for so many.

Through a personalised programme of complementary care, Breast Cancer Haven provides essential mental, emotional and physical support to anyone who needs it.

Following the coronavirus lockdown, Breast Cancer Haven swiftly adapted to delivering services online and over the telephone, which has allowed a greater geographical reach and improved access across the entire United Kingdom.

Despite the significant financial impact caused by this pandemic, all of these programmes of care are still offered free of charge.

I can only express my most heartfelt gratitude to all who have supported the work of Breast Cancer Haven this year, and who have made it possible for more and more people to look forward with hope.

OUR BOARD OF TRUSTEES

PROFESSOR DUDLEY SINNETT MS FRCS

Previously a Professor of Breast Surgery at Imperial College London, Dudley’s first Consultant post was as Senior Lecturer at the Institute of Cancer Research and honorary Consultant Surgeon at the Royal Marsden Hospital. From 1989 to 2009 he worked at Charing Cross Hospital and, whilst there, became Consultant Breast Surgeon and Director of Breast Services. He has been the Quality Assurance Surgeon for the surgical aspects of the National Breast Screening programme in London. Dudley has been the national secretary of the British Association of Surgical Oncology and helped produce the national surgical guidelines for the treatment of breast cancer and serving on the BASO national committee. He has previously been a member of the Medical Advisory Committee of Breast Cancer Care and has published a number of papers on breast disease and DVDs for the BMA and the National Breast Screening programme. Dudley first joined our Board of Trustees in 2007 and became our Chairman in January 2018.

PETER BALL

Peter Bell is a specialist in branding and engagement and has worked for high profile blue chip companies including Unilever, Whitbread and BSkyB. He was a founder director of the business coaching company The Coaching House and then became a director and major shareholder of the Added Value Group, helping it grow in to one of the world’s largest marketing consultancies. Following Added Value’s sale to WPP he ran the global engagement practice for The Brand Union until starting his own consultancy Bell Brand Engagement. He is a Fellow of the Marketing Society and a non-executive director of La Chispa.

DORINDA HICKEY

Dorinda has had a long career in senior roles within the pharmaceutical industry. Graduating with a PhD in Haematology from Trinity College, Dublin, she started her career as a research assistant at St James’s Hospital, Dublin, before moving to Sandoz UK and subsequently Novartis in a variety of sales, marketing, business intelligence and general management roles. In 2005, Dorinda moved into consultancy and was founding partner of Navigate Health LLP, working for both pharmaceutical industry and NHS clients. Dorinda has clinical research and commercial experience in a wide variety of therapy areas including oncology, haematology and dermatology. She has recently completed a master’s degree in Health Economics, Policy and Management at the London School of Economics and Political Science.

ALASTAIR KING

Alastair is Vice Chairman of the Board of Breast Cancer Haven since September 2017.  He is Founder and Chairman of Naisbitt King Asset Management Limited (NKAML), an independent, FCA-regulated fund management firm, headquartered in the City of London. Alastair was elected as Alderman of the Ward of Queenhithe in the City of London, in November 2016.

Alastair is European Education Chairman (2016-2018) of the Young President’s Organisation (YPO), the world’s premier peer network of young chief executives, Co-Chair of the YPO London Star Chapter and Chairman of the Haringey Project for “On-Side” – a leading provider of youth clubs (“Youth Zones”) in deprived metropolitan areas.

 

PIPPA LAMBERT

Ms Pippa Lambert is currently Global Head of HR for the Deutsche Bank, with responsibility for the Bank’s worldwide Human Resources organisation. She was the Director of Global Reward at the Royal Bank of Scotland from 2011-2013. Prior to that, Ms Lambert held several positions with Deutsche Bank. She has recently been appointed as a member of the Senior Salaries Review Board.

LORD ROCKLEY FCA

Lord Anthony Rockley joined The Haven as a Trustee in 2013. He was a partner of KPMG in London, working exclusively with Private Equity Funds. He joined Peats in 1983 and has remained there ever since. Throughout the 90s he worked extensively in KPMG’s offices in the emerging markets of Eastern Europe, but is now UK based. He lives in Dorset where he divides his spare time between gardening and country sports.

Anthony sits on our Audit Committee and he is a trustee of the Worcester Breast Cancer Haven Board.

 

PROFESSOR IAN SMITH

Ian Smith is Professor of Cancer Medicine at The Royal Marsden and the Institute of Cancer Research. He has spent his career as a breast cancer specialist and for many years he was Head of the Breast Unit at The Royal Marsden. His initial medical training was in Edinburgh and then he came to The Royal Marsden for specialist training in cancer medicine. He also spent some time in Boston at the Dana-Farber Cancer Institute, Harvard. Over the years his principal clinical research interests have been in breast cancer, lung cancer and new drug development. He was involved in the early clinical development of several anti-cancer drugs that have subsequently proved effective in the clinic, including carboplatin and letrozole.

For much of his career he has been involved in neoadjuvant (preoperative) therapies as a research approach towards individualised treatments for breast cancer, and he has led for several international multicentre breast cancer trials involving new approaches to treatment. He publishes and lectures extensively. He was awarded the Susan G Komen for the Cure Brinker Award for Scientific Distinction at the 2009 San Antonio International Breast Cancer Conference, and in 2017 he was given the William McGuire Memorial Award and Lecture at the same conference, one of the highest honours in the field.

 

CHRIS WHITWORTH FCA

Chris took a degree in Economics at University College, London and in 1971 qualified as a Chartered Accountant with a City firm that is now merged with Ernst & Young. In 1972 he moved to Montreal, Canada and worked with KPMG for two years, following which he worked in a variety of financial positions in manufacturing, foreign exchange and consulting engineering. In 1982 he moved to Houston, Texas where he was VP Finance and subsequently President of a geological research company. He returned to the UK in 1987 to join the FCB Advertising group as Group Finance Director, and following the merger of the FCB and Publicis European groups in 1990 he was first UK Group FD for the enlarged Publicis-FCB Group and in 1997 was additionally appointed as Northern Europe FD.

In 2000 he joined the Omnicom/DAS-owned WWAV Rapp Collins, the UK’s largest Direct Marketing agency, as Group FD, and in 2003 he moved to his present position as DAS’s International CFO. Chris works extensively with the UK advertising industry trade bodies. He is a Council member and former Hon Treasurer of the IPA, and also a trustee director of the IPA Portable Pension Scheme. He is Chairman of the Finance Committee of the Advertising Association and a director of Asbof.

 

 

SPENCER LESLIE

Spencer Leslie is a Chartered Accountant who has worked in the Property development industry over the last 20 years. 

He was originally the owner of the Supercuts Hairdressing chain in the 1990’s.

Spencer has been heavily involved with breast cancer charities for over 15 years.

 

OUR DIRECTORS

Dr Caroline Hoffman OAM, PhD, RN, BSW | DIRECTOR

Caroline has specialised in integrative healthcare for over 30 years both in the NHS and voluntary sector. She was awarded the Medal of the Order of Australia (OAM) for her contribution to breast cancer support services in 2014. Her last NHS role was as the first Nurse Consultant in Cancer Rehabilitation at the Royal Marsden NHS Foundation Trust. Caroline has  long-standing expertise in psychosocial support, nursing and complementary medicine and research. Her doctoral research showed significant benefits from the mindfulness-based stress reduction programme (MBSR) in people affected by breast cancer and was published in the Journal of Clinical Oncology in 2012. Caroline teaches 8-week MBSR and Mindful Self-Compassion courses. She is a member of the Society of Integrative Oncology and on the Committee of the British Society of Integrative Oncology. Caroline is currently working two days per week for Breast Cancer Haven.

 

MARK GUILFORD FCA | FINANCE DIRECTOR

Mark is a Chartered Accountant and spent the first 10-years of his career in the accounting profession with Price Waterhouse (now PwC) as an auditor, computer auditor and management consultant. He then worked for 8 years for a PW client in a variety of commercial finance roles, in the UK and France, in the printing and direct marketing sector. This was followed by 3 years in the Netherlands working as European Finance Director and Managing Director of the Benelux operations for a US family-owned manufacturing and distribution business.

On his return to the UK in 2005 Mark became an interim Finance Director where he has worked for a variety of organisations for UK quoted companies, Private Equity backed organisations, and for family-owned businesses, in the manufacturing, distribution, professional services, technology and house-building sectors. Other clients include local authorities, hospitals, charities and not-for-profit organisations. Mark came to Breast Cancer Haven as an interim consultant in December 2018. In March 2019 he became Finance Director. Mark is currently working two days per week for Breast Cancer Haven.

 

Make a donation

Help us to support more people through the toughest times of their lives

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more